Although efforts have been made to improve the pharmacological treatment of depression,approximately one-third of patients with depression do not respond to conventional therapy using antidepressants.Other potential n...Although efforts have been made to improve the pharmacological treatment of depression,approximately one-third of patients with depression do not respond to conventional therapy using antidepressants.Other potential non-pharmacological therapies have been studied in the last years,including the use of mesenchymal stem cell therapies to treat depression.These therapies are reviewed here since it is clinically relevant to develop innovative therapeutics to treat psychiatric patients.Experimental data corroborate that mesenchymal stem cell therapy could be considered a potential treatment for depression based on its antiinflammatory and neurotrophic properties.However,some clinical trials involving treatment of depression with stem cells are in progress,but with no published results.These studies and other future clinical investigations will be crucial to define how much mesenchymal stem cells can effectively be used in psychiatric clinics as a strategy for supporting depression treatment.展开更多
基金Supported by Conselho Nacional de Desenvolvimento Cientifico-CNPq.
文摘Although efforts have been made to improve the pharmacological treatment of depression,approximately one-third of patients with depression do not respond to conventional therapy using antidepressants.Other potential non-pharmacological therapies have been studied in the last years,including the use of mesenchymal stem cell therapies to treat depression.These therapies are reviewed here since it is clinically relevant to develop innovative therapeutics to treat psychiatric patients.Experimental data corroborate that mesenchymal stem cell therapy could be considered a potential treatment for depression based on its antiinflammatory and neurotrophic properties.However,some clinical trials involving treatment of depression with stem cells are in progress,but with no published results.These studies and other future clinical investigations will be crucial to define how much mesenchymal stem cells can effectively be used in psychiatric clinics as a strategy for supporting depression treatment.
